Monday, September 14, 2020: 8:35 AM - 9:30 AM
SESSION CHAIRS & SPEAKERS
After the keynote address, Debra Jendrasek (Premier Research, Adaptive Clinical Research Partner) will moderate a leadership panel; wherein, Hans Constandt (Ontoforce CEO) will be joined by Mark Wheeldon (Formedix CEO), Michelle Longmire (Medable CEO), and Khrystal Davis (Texas Rare Disease patient advocate). They will discuss not only Hans’ Keynote address with respect to data quality and Artificial Intelligence leading to timely data insights, but also touchpoints on the theme of our conference with respect to communicate, explore and pioneer. Insights on metadata leveraging for CDISC submissions, including conversion process automation will be discussed. They will delve into how patient stakeholdership is continuing to change the conversation around informed consent and sharing of data as new sources of data like newborn genomes emerge. The adaptation of database design and technology advancement will also be touched upon, including how communication with regulatory agencies are evolving and clinical data managers continue their maturation into clinical data scientists in the eye of a data tsunami and global pandemic!